IT - EN - DE     Finceramica

 
   

 

04/08/2016

Lunch Symposium An Evidence based Step Ahead in the Treatment of OC Lesions Results of an International RCT


 Finceramica welcome you to this Lunch Symposium where the results from our International Study comparing MaioRegen bio-mimetic osteochondral scaffold to bone marrow stimulation techniques will be officially presented.

This Level of Evidence 1 Randomized Controlled Trial confirms MaioRegen as a “step ahead” in the treatment of osteochondral lesions.


We are looking forward to sharing these important results with you!




   

27/01/2012

Finceramica selected as a finalist in the GOOD Company Project by IBM, GOOD's partner

27/07/2011

MaioRegen WEB Registry

1  2  3  4  5